Market Indices
Sector Heatmap
CATX — Perspective Therapeutics, Inc.
NYSE AmericanPerspective Therapeutics, Inc.
- O
- 2.77
- H
- 2.82
- L
- 2.69
- V
- 2.62M
CATX — Latest News & Headlines
15 StoriesPerspective Therapeutics, Inc. (CATX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Perspective Therapeutics, Inc. (CATX) Stock Price, News, Quote & History Yahoo! Finance Canada
$CATX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
$CATX stock is down 11% today. Here's what we see in our data. Quiver Quantitative
A study of a targeted melanoma treatment will be presented at a cancer meeting in November. - stocktitan.net
A study of a targeted melanoma treatment will be presented at a cancer meeting in November. stocktitan.net
Catalyst One Exploration Corp. Advanced Charts | CATX - Barron's
Catalyst One Exploration Corp. Advanced Charts | CATX Barron's
After selling nearly 1.4 million shares in one day, a Perspective Therapeutics (CATX) holder still has a stake. - stocktitan.net
After selling nearly 1.4 million shares in one day, a Perspective Therapeutics (CATX) holder still has a stake. stocktitan.net
Catalyst One Exploration Corp. Financial Statements – TSXV:CATX - tradingview.com
Catalyst One Exploration Corp. Financial Statements – TSXV:CATX tradingview.com
Catalyst One Exploration Corp. (CATX.V) Stock Price, News, Quote & History - Yahoo! Finance Canada
Catalyst One Exploration Corp. (CATX.V) Stock Price, News, Quote & History Yahoo! Finance Canada
Perspective Therapeutics (CATX) Climbs 3.13% to $2.97, Nearing Resistance at $3.12 - Mutual Fund Flow - dars.gov.et
Perspective Therapeutics (CATX) Climbs 3.13% to $2.97, Nearing Resistance at $3.12 - Mutual Fund Flow dars.gov.et
Three cancer programs are in trials. Perspective Therapeutics (CATX) reports early melanoma results. - stocktitan.net
Three cancer programs are in trials. Perspective Therapeutics (CATX) reports early melanoma results. stocktitan.net
Perspective Therapeutics’ [212Pb]VMT01 Melanoma Data Accepted for Presentation at 2026 SITC Annual Meeting - Quiver Quantitative
Perspective Therapeutics’ [212Pb]VMT01 Melanoma Data Accepted for Presentation at 2026 SITC Annual Meeting Quiver Quantitative
Perspective Therapeutics (CATX) Climbs 3.13% to $2.97, Nearing Resistance at $3.12 - Spring Pattern - dars.gov.et
Perspective Therapeutics (CATX) Climbs 3.13% to $2.97, Nearing Resistance at $3.12 - Spring Pattern dars.gov.et
Catalyst One Exploration Corp. (CATX.V) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Catalyst One Exploration Corp. (CATX.V) Analyst Insights, Price Targets & Recommendations Yahoo! Finance Canada
Catalyst One Exploration Corp. (CATX.V) Insider Ownership & Holdings - Yahoo! Finance Canada
Catalyst One Exploration Corp. (CATX.V) Insider Ownership & Holdings Yahoo! Finance Canada
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline - TipRanks
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline TipRanks
3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside - TipRanks
3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside TipRanks